Search:

Login | Subscribe

Home > Companies > Alizyme

Price	Market	Sector	Market Cap
7.13p (-1.50p) -17.38%	LSE	Medicine and Biotech Research	£15.76m

Add to company folder | Print

Related Companies

ACM	p
ASM	23.25p	-2.10%
ARA	6.50p	0.00%
AKT	36.25p	0.69%
AZN	2475.00p	2.27%
DPH	346.00p	-3.89%
GSK	1120.50p	1.73%
GSD	210.00p	6.60%
OXB	6.00p	0.00%
PYM	6.13p	0.00%
PTI	46.25p	-1.60%
SHP	910.00p	1.62%
SPH	17.00p	1.49%
SKP	143.00p	0.35%
VEC	48.00p	-2.04%
VER	3.33p	-5.67%

Recent Articles

Market Watch - TechMARK	08/08/2006
Runners and riders in the medical stakes	10/04/2006
TechMark Report	04/11/2003
Alizyme	24/04/2003
Cash drains at Alizyme	26/07/2002
Alizyme	25/07/2002
techMark endures rough ride	01/07/2002
Alizyme	19/06/2002
Alizyme	15/05/2002
Drug-induced investments	01/05/2002
More

Recent Announcements

Interim Management Statement	19/11/2008
Price Monitoring Extension	31/10/2008
Notification of Shares	15/10/2008
Notification of shares	26/09/2008
Major Interest in Shares	23/09/2008
TAKEDA Milestone Payment	16/09/2008
Major Interest in Shares	11/09/2008
Update on Board Change	05/09/2008
Interim Results	29/08/2008
Block Listing Six Monthly Ret	19/08/2008
More

Articles from the Sector

Stroke hope at ReNeuron	28/11/2008
Futura Medical	28/11/2008
Option deal boosts ImmuPharma	25/11/2008
Digital imager targets AIM	24/11/2008
Vectura loses interim £11.7m	24/11/2008
GW trims loss	19/11/2008
Asterand	18/11/2008
EU trial cheers Plethora	07/11/2008
IS Pharma	05/11/2008
Animalcare nurturing high-margin growth	03/11/2008
More

Financial History

Financial Year End	31/12/2003	31/12/2004	31/12/2005	31/12/2006	31/12/2007
Currency	GBP	GBP	GBP	GBP	GBP
Turnover	1.24	1.65	0.00	1.13	0.01
Operating Profit	-11.34	-6.11	-18.90	-19.68	-33.51
Pretax Profit	-10.82	-5.27	-17.60	-18.97	-32.70
Earnings After Tax	-10.01	-4.61	-16.71	-17.96	-31.25
Profit Available For Dividend	0.00	0.00	0.00	0.00	0.00
Ordinary Dividends	0.00	0.00	0.00	0.00	0.00
Retained Profit	-10.01	0.00	0.00	0.00	0.00
Shareholders Funds	20.79	16.65	31.85	30.43	0.50
Net Current Assets	20.96	0.00	0.00	0.00	0.00
Adjusted Earnings Per Share Undiluted	0.00	-3.20	0.00	-9.90	-15.60
Adj Earnings Per Share	0.00	-3.20	0.00	-9.90	-15.60
Dividend Per Share	0.00	0.00	0.00	0.00	0.00

Chart

Click here for interactive charting

Company Details
Address
Telephone
Fax
Advisers
Nominated Adviser
Nominated Broker
Solicitors
Auditors
Registrar

Company Data
Code	AZM
Sedol	GB00003742
Shares In Issue	221.099 m
Indices
Entry on AIM
Interim Results
Final Results
Year End
Accounts Due
Int div payment
Fin div payment
Int net div per share
Fin net div per share
Probable CGT relief